Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHCONASDAQ:CELCNASDAQ:GRALNYSE:TDOC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$9.06-2.1%$9.13$7.11▼$11.90$1.22B1.641.28 million shs900,349 shsCELCCelcuity$10.60-0.5%$10.17$7.58▼$19.77$401.09M0.56298,499 shs124,620 shsGRALGrail$37.46-4.7%$30.41$12.33▼$63.99$1.35BN/A1.26 million shs1.00 million shsTDOCTeladoc Health$6.99-4.8%$7.52$6.35▼$15.21$1.23B1.826.23 million shs3.78 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth+2.89%+2.55%+18.74%+2.78%-6.47%CELCCelcuity-0.37%-1.57%+4.00%-19.07%-36.61%GRALGrail+2.85%-8.32%+45.63%-25.25%+3,931,999,900.00%TDOCTeladoc Health+0.27%-3.81%+7.40%-46.98%-40.38%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAHCOAdaptHealth2.3431 of 5 stars3.51.00.00.01.31.71.9CELCCelcuity2.1662 of 5 stars3.61.00.00.03.32.50.0GRALGrail0.7881 of 5 stars1.12.00.00.04.10.80.6TDOCTeladoc Health3.7078 of 5 stars4.22.00.00.04.02.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHCOAdaptHealth 3.00Buy$13.4047.90% UpsideCELCCelcuity 3.17Buy$30.80190.57% UpsideGRALGrail 2.25Hold$31.50-15.91% DownsideTDOCTeladoc Health 2.37Hold$9.7138.99% UpsideCurrent Analyst Ratings BreakdownLatest CELC, GRAL, TDOC, and AHCO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$27.00 ➝ $27.005/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00 ➝ $29.005/14/2025GRALGrailCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$32.00 ➝ $43.005/12/2025AHCOAdaptHealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $13.005/8/2025AHCOAdaptHealthRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$14.00 ➝ $13.005/8/2025TDOCTeladoc HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.005/1/2025TDOCTeladoc HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.005/1/2025TDOCTeladoc HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$13.00 ➝ $10.005/1/2025TDOCTeladoc HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$9.00 ➝ $8.005/1/2025TDOCTeladoc HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$8.00 ➝ $7.005/1/2025TDOCTeladoc HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 5/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHCOAdaptHealth$3.25B0.38$11.19 per share0.81$11.06 per share0.82CELCCelcuityN/AN/AN/AN/A$5.48 per shareN/AGRALGrail$130.71M10.31N/AN/AN/A∞TDOCTeladoc Health$2.55B0.48$0.45 per share15.64$14.05 per share0.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHCOAdaptHealth-$678.90M$0.57N/A9.341.08-6.57%9.62%3.18%8/5/2025 (Estimated)CELCCelcuity-$63.78M-$3.03N/AN/AN/AN/A-62.66%-39.78%N/AGRALGrailN/A-$60.99N/AN/AN/AN/AN/AN/AN/ATDOCTeladoc Health-$220.37M-$5.92N/AN/AN/A-37.91%-10.06%-4.86%7/30/2025 (Estimated)Latest CELC, GRAL, TDOC, and AHCO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025CELCCelcuity-$0.95-$0.86+$0.09-$0.86N/AN/A5/13/2025Q1 2025GRALGrail-$4.03-$3.10+$0.93-$3.10$35.80 million$31.84 million3/31/2025Q4 2024CELCCelcuity-$0.72-$0.85-$0.13-$0.85N/AN/A2/26/2025Q4 2024TDOCTeladoc Health-$0.21-$0.28-$0.07-$0.28$639.44 million$640.49 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAHCOAdaptHealthN/AN/AN/AN/AN/ACELCCelcuityN/AN/AN/AN/AN/AGRALGrailN/AN/AN/AN/AN/ATDOCTeladoc HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHCOAdaptHealth1.341.241.00CELCCelcuity0.6510.3510.36GRALGrailN/A9.659.65TDOCTeladoc Health0.661.731.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHCOAdaptHealth82.67%CELCCelcuity63.33%GRALGrailN/ATDOCTeladoc Health76.82%Insider OwnershipCompanyInsider OwnershipAHCOAdaptHealth1.55%CELCCelcuity15.77%GRALGrail1.85%TDOCTeladoc Health0.58%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHCOAdaptHealth10,900134.95 million128.59 millionOptionableCELCCelcuity4037.84 million31.27 millionOptionableGRALGrail1,36035.97 millionN/AOptionableTDOCTeladoc Health5,100175.44 million170.53 millionOptionableCELC, GRAL, TDOC, and AHCO HeadlinesRecent News About These CompaniesCresset Asset Management LLC Sells 83,430 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 21 at 3:51 AM | marketbeat.comAmeriprise Financial Inc. Lowers Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)May 21 at 3:27 AM | marketbeat.comAnalysts Offer Predictions for Teladoc Health Q2 EarningsMay 20 at 1:17 AM | americanbankingnews.comZacks Research Expects Stronger Earnings for Teladoc HealthMay 20 at 1:16 AM | marketbeat.comTeladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Point72 Asset Management L.P.May 17, 2025 | marketbeat.comNorthern Trust Corp Acquires 161,875 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 17, 2025 | marketbeat.comTeladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin PressureMay 16, 2025 | benzinga.comMoore Capital Management LP Buys Shares of 178,461 Teladoc Health, Inc. (NYSE:TDOC)May 15, 2025 | marketbeat.comAlgert Global LLC Invests $313,000 in Teladoc Health, Inc. (NYSE:TDOC)May 15, 2025 | marketbeat.comTeladoc Health (NYSE:TDOC) Reports Q1 2025 Net Loss Of US$93 MillionMay 13, 2025 | finance.yahoo.comInvenomic Capital Management LP Sells 500,687 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 13, 2025 | marketbeat.comFirst Trust Advisors LP Sells 48,610 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 13, 2025 | marketbeat.comCentiva Capital LP Boosts Stock Position in Teladoc Health, Inc. (NYSE:TDOC)May 9, 2025 | marketbeat.comBrevan Howard Capital Management LP Purchases 75,961 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 9, 2025 | marketbeat.comTeladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from BrokeragesMay 9, 2025 | marketbeat.comTDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care UnitMay 8, 2025 | zacks.comCastleKnight Management LP Increases Stake in Teladoc Health, Inc. (NYSE:TDOC)May 8, 2025 | marketbeat.comCantor Fitzgerald Cuts Earnings Estimates for Teladoc HealthMay 6, 2025 | marketbeat.comQ2 EPS Estimates for Teladoc Health Decreased by AnalystMay 6, 2025 | marketbeat.com177,651 Shares in Teladoc Health, Inc. (NYSE:TDOC) Acquired by Freestone Grove Partners LPMay 5, 2025 | marketbeat.comBrokers Set Expectations for Teladoc Health Q1 EarningsMay 4, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCELC, GRAL, TDOC, and AHCO Company DescriptionsAdaptHealth NASDAQ:AHCO$9.06 -0.19 (-2.05%) Closing price 04:00 PM EasternExtended Trading$9.07 +0.01 (+0.11%) As of 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Celcuity NASDAQ:CELC$10.60 -0.05 (-0.47%) Closing price 04:00 PM EasternExtended Trading$10.79 +0.19 (+1.78%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.Grail NASDAQ:GRAL$37.46 -1.86 (-4.73%) Closing price 04:00 PM EasternExtended Trading$37.17 -0.29 (-0.77%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.Teladoc Health NYSE:TDOC$6.98 -0.36 (-4.84%) Closing price 03:59 PM EasternExtended Trading$6.99 +0.00 (+0.07%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Could Rally as EU Antitrust Case Nears Resolution Canada Goose Soars 30%—Is This Rally Built to Last? Palo Alto Networks: Buy The Dip, Long-Term Tailwinds Ahead Lowe’s Stock Uptrend Can Continue for These 2 Reasons CrowdStrike Near Breakout: Is Now the Time to Buy? $30B AI Opportunity: Will It Power Meta’s Next Surge? Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era Rivian Stock Below $20: Charging Up or in the Breakdown Lane? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
